Literature DB >> 1639514

Elevated body temperature restricts growth of Haemophilus influenzae type b during experimental meningitis.

T O'Reilly1, O Zak.   

Abstract

Elevation of the environmental temperature appeared to counteract the temperature-depressing effects of urethane anesthetic and allowed rabbits intracisternally infected with Haemophilus influenzae type b to mimic the development of a fever following infection. Elevated core body temperature (greater than 39 degrees C) was associated with an inhibition of the growth of H. influenzae in cerebrospinal fluid (CSF) during the first 12 h postinfection, whereas bacterial growth was essentially unrestricted in rabbits with reduced (approximately 37 degrees C) body temperature. Bacterial densities 24 h postinfection were different, hyperthermic animals having log 6.0 +/- 0.4 CFU/ml of CSF and hypothermic rabbits having log 8.2 +/- 0.8 CFU/ml of CSF (P less than 0.05, Wilcoxon rank sum test). However, the growth of this bacterium in vitro, in either pooled rabbit CSF or brain heart infusion broth, was not inhibited at 39 degrees C. These results suggest that elevated body temperature associated with the development of fever during meningitis may be associated with restriction of the growth of H. influenzae in vivo but that this effect is apparently not due to an innate inability of the bacterium to grow at elevated temperatures.

Entities:  

Mesh:

Year:  1992        PMID: 1639514      PMCID: PMC257336          DOI: 10.1128/iai.60.8.3448-3451.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  Fever as a mechanism of resistance.

Authors:  I L BENNETT; A NICASTRI
Journal:  Bacteriol Rev       Date:  1960-03

2.  Clearance of bacteria from cerebrospinal fluid to blood in experimental meningitis.

Authors:  W M Scheld; T S Park; R G Dacey; H R Winn; J A Jane; M A Sande
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

3.  Report of the Task Force on Diagnosis and Management of Meningitis.

Authors:  J O Klein; R D Feigin; G H McCracken
Journal:  Pediatrics       Date:  1986-11       Impact factor: 7.124

4.  The influence of fever on the development of experimental Streptococcus pneumoniae meningitis.

Authors:  M A Sande; E R Sande; J D Woolwine; C J Hackbarth; P M Small
Journal:  J Infect Dis       Date:  1987-11       Impact factor: 5.226

5.  Fever in adult patients with acute bacterial meningitis.

Authors:  P Domingo; J Mancebo; L Blanch; A Net; J Nolla
Journal:  J Infect Dis       Date:  1988-08       Impact factor: 5.226

Review 6.  Is suppression of fever or hypothermia useful in experimental and clinical infectious diseases?

Authors:  J Klastersky; E H Kass
Journal:  J Infect Dis       Date:  1970-01       Impact factor: 5.226

7.  Absence of detectable bactericidal and opsonic activities in normal and infected human cerebrospinal fluids. A regional host defense deficiency.

Authors:  M S Simberkoff; N H Moldover; J Rahal
Journal:  J Lab Clin Med       Date:  1980-03

8.  Deficient cerebrospinal fluid opsonization in experimental Escherichia coli meningitis.

Authors:  L L Bernhardt; M S Simberkoff; J J Rahal
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

9.  Experimental pneumococcal meningitis: role of leukocytes in pathogenesis.

Authors:  J D Ernst; J M Decazes; M A Sande
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

10.  Influence of body temperature on bacterial growth rates in experimental pneumococcal meningitis in rabbits.

Authors:  P M Small; M G Täuber; C J Hackbarth; M A Sande
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

View more
  1 in total

1.  Mupirocin-induced mutations in ileS in various genetic backgrounds of methicillin-resistant Staphylococcus aureus.

Authors:  Andie S Lee; Yann Gizard; Joanna Empel; Eve-Julie Bonetti; Stephan Harbarth; Patrice François
Journal:  J Clin Microbiol       Date:  2014-08-13       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.